Tengxiang Chen

776 total citations
48 papers, 516 citations indexed

About

Tengxiang Chen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tengxiang Chen has authored 48 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tengxiang Chen's work include RNA modifications and cancer (9 papers), Reproductive Biology and Fertility (7 papers) and MicroRNA in disease regulation (7 papers). Tengxiang Chen is often cited by papers focused on RNA modifications and cancer (9 papers), Reproductive Biology and Fertility (7 papers) and MicroRNA in disease regulation (7 papers). Tengxiang Chen collaborates with scholars based in China, Australia and United Kingdom. Tengxiang Chen's co-authors include Zhirui Zeng, Shan Lei, Zhiwei He, Jianxin Jiang, Tuo Zhang, Jinjuan Zhang, Chao Wang, Xingjun Guo, Meina He and Bing Guo and has published in prestigious journals such as Nucleic Acids Research, ACS Nano and Cancer Research.

In The Last Decade

Tengxiang Chen

43 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tengxiang Chen China 12 294 181 76 70 66 48 516
Patrycja Sosińska Poland 15 244 0.8× 87 0.5× 69 0.9× 127 1.8× 21 0.3× 29 564
Shoubin Zhan China 11 331 1.1× 219 1.2× 30 0.4× 66 0.9× 22 0.3× 15 522
Zhiqin Fu China 12 254 0.9× 148 0.8× 41 0.5× 96 1.4× 11 0.2× 34 533
Floriana Centritto Italy 10 268 0.9× 76 0.4× 45 0.6× 140 2.0× 132 2.0× 11 624
Kamilla Stach Poland 8 196 0.7× 113 0.6× 61 0.8× 103 1.5× 18 0.3× 10 499
Lorand Magdo Romania 9 582 2.0× 408 2.3× 81 1.1× 64 0.9× 24 0.4× 13 759
WEN-SHIN CHANG Taiwan 12 250 0.9× 158 0.9× 57 0.8× 125 1.8× 23 0.3× 74 527
Shengbin Dai China 12 291 1.0× 118 0.7× 91 1.2× 96 1.4× 44 0.7× 28 490
Anna Junjie Shangguan China 8 176 0.6× 61 0.3× 31 0.4× 134 1.9× 22 0.3× 12 403

Countries citing papers authored by Tengxiang Chen

Since Specialization
Citations

This map shows the geographic impact of Tengxiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tengxiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tengxiang Chen more than expected).

Fields of papers citing papers by Tengxiang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tengxiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tengxiang Chen. The network helps show where Tengxiang Chen may publish in the future.

Co-authorship network of co-authors of Tengxiang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Tengxiang Chen. A scholar is included among the top collaborators of Tengxiang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tengxiang Chen. Tengxiang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Zhirui, Wenjing Tang, Dahuan Li, et al.. (2025). Bioinformatics Combined With Biological Experiments to Identify the Pathogenetic Link of Type 2 Diabetes for Breast Cancer. Cancer Medicine. 14(7). e70759–e70759.
2.
Zhang, Tuo, et al.. (2025). MEN1 Promotes Ferroptosis by Disrupting CD44 Alternative Splicing to Suppress Lung Cancer. Cancer Research. 86(1). 146–166.
3.
Wu, Yingmin, Lian Li, Long Wang, et al.. (2024). m1A regulator-mediated methylation modification patterns correlated with autophagy to predict the prognosis of hepatocellular carcinoma. BMC Cancer. 24(1). 506–506. 4 indexed citations
4.
Zhang, Tuo, Jin Niu, Tianhe Ren, et al.. (2024). METTL3 prevents granulosa cells mitophagy by regulating YTHDF2-mediated BNIP3 mRNA degradation due to arsenic exposure. Ecotoxicology and Environmental Safety. 286. 117233–117233. 2 indexed citations
5.
Li, Dahuan, et al.. (2024). Identification of Clinical Value and Biological Effects of XIRP2 Mutation in Hepatocellular Carcinoma. Biology. 13(8). 633–633. 2 indexed citations
6.
Lei, Shan, et al.. (2024). Cynaroside Induces G1 Cell Cycle Arrest by Downregulating Cell Division Cycle 25A in Colorectal Cancer. Molecules. 29(7). 1508–1508. 4 indexed citations
7.
Zhang, Shilong, Lian Li, Yewei Zhang, et al.. (2024). NAP1L1 regulates BIRC2 ubiquitination modification via E3 ubiquitin ligase UBR4 and hence determines hepatocellular carcinoma progression. Cell Death Discovery. 10(1). 154–154. 3 indexed citations
8.
Luo, Fang, Lingyi Shen, Jinjuan Zhang, et al.. (2023). Nanoarchitectonics of the aggregation-induced emission luminescent molecule Tetraphenylethylene-COOH (TPE-COOH): Fluorescence imaging of targeted cancer microsphere cells. Dyes and Pigments. 214. 111192–111192. 4 indexed citations
9.
Zeng, Zhirui, Lian Li, Shan Lei, et al.. (2023). Sinapine thiocyanate exhibited anti-colorectal cancer effects by inhibiting KRT6A/S100A2 axis. Cancer Biology & Therapy. 24(1). 2249170–2249170. 5 indexed citations
10.
Ren, Tianhe, et al.. (2023). [p53 regulates primordial follicle activation through the mTOR signaling pathway].. PubMed. 75(3). 339–350. 2 indexed citations
11.
Chen, Tengxiang, et al.. (2023). [Oenothein B inhibits proliferation and migration of breast cancer cells by regulating P53].. PubMed. 48(14). 3904–3912. 1 indexed citations
12.
Zuo, Shi, et al.. (2023). MIA3 promotes the degradation of GSH (glutathione) by binding to CHAC1, thereby promoting the progression of hepatocellular carcinoma. Molecular and Cellular Biochemistry. 479(10). 2769–2784. 10 indexed citations
13.
Zhu, Jiamei, Ting Pan, Yüxia Zhou, et al.. (2023). MEN1 is a regulator of alternative splicing and prevents R-loop-induced genome instability through suppression of RNA polymerase II elongation. Nucleic Acids Research. 51(15). 7951–7971. 13 indexed citations
14.
Lei, Shan, Wenpeng Cao, Zhirui Zeng, et al.. (2022). JUND/linc00976 promotes cholangiocarcinoma progression and metastasis, inhibits ferroptosis by regulating the miR-3202/GPX4 axis. Cell Death and Disease. 13(11). 967–967. 38 indexed citations
15.
Jiang, Yinhui, et al.. (2022). Dietary Vitamin K Intake and HPV-Infection Status Among American Women: A Secondary Analysis From National Health and Nutrition Examination Survey Data From 2003 to 2016. International Journal of Public Health. 67. 1604616–1604616. 7 indexed citations
16.
Zeng, Zhirui, Dan Ma, Zhi-Xin Yin, et al.. (2022). Discovery of novel IDH1-R132C inhibitors through structure-based virtual screening. Frontiers in Pharmacology. 13. 982375–982375. 5 indexed citations
17.
Wang, Jingya, Zhirui Zeng, Shan Lei, et al.. (2022). Sinapine Thiocyanate Inhibits the Proliferation and Mobility of Pancreatic Cancer Cells by Up-Regulating GADD45A. Journal of Cancer. 13(4). 1229–1240. 9 indexed citations
18.
Zeng, Zhirui, Shan Lei, Zhiwei He, Tengxiang Chen, & Jianxin Jiang. (2020). YEATS2 is a target of HIF1α and promotes pancreatic cancer cell proliferation and migration. Journal of Cellular Physiology. 236(3). 2087–2098. 33 indexed citations
19.
Chen, Tengxiang, Shan Lei, Zhirui Zeng, et al.. (2020). Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis. Oncology Reports. 43(3). 930–942. 30 indexed citations
20.
Lei, Shan, Zhiwei He, Tengxiang Chen, et al.. (2019). Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 470–470. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrycja Sosińska Breakdown of academic impact, for papers by Shoubin Zhan Breakdown of academic impact, for papers by Zhiqin Fu Breakdown of academic impact, for papers by Floriana Centritto Breakdown of academic impact, for papers by Kamilla Stach Breakdown of academic impact, for papers by Lorand Magdo Breakdown of academic impact, for papers by WEN-SHIN CHANG Breakdown of academic impact, for papers by Shengbin Dai Breakdown of academic impact, for papers by Anna Junjie Shangguan
Rankless by CCL
2026